Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus Sells 8,078 Shares

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 8,078 shares of Oscar Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the transaction, the chief accounting officer now owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Oscar Health Stock Performance

Oscar Health stock traded down $0.44 during mid-day trading on Tuesday, hitting $17.99. The company had a trading volume of 6,121,611 shares, compared to its average volume of 3,427,490. The company has a market capitalization of $4.45 billion, a price-to-earnings ratio of -307.12 and a beta of 1.64. Oscar Health, Inc. has a 12-month low of $7.50 and a 12-month high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company’s fifty day moving average is $17.33 and its 200-day moving average is $17.99.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.33 billion. During the same quarter in the previous year, the firm posted ($0.29) earnings per share. The business’s revenue was up 68.3% compared to the same quarter last year. Equities research analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Analyst Ratings Changes

OSCR has been the subject of a number of recent research reports. Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group initiated coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Finally, Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $22.93.

Institutional Trading of Oscar Health

Several large investors have recently added to or reduced their stakes in OSCR. Janney Montgomery Scott LLC acquired a new stake in Oscar Health during the 3rd quarter worth approximately $988,000. Versor Investments LP acquired a new position in Oscar Health during the third quarter worth about $787,000. Algert Global LLC increased its position in shares of Oscar Health by 63.3% in the third quarter. Algert Global LLC now owns 369,685 shares of the company’s stock valued at $7,841,000 after buying an additional 143,346 shares in the last quarter. Intech Investment Management LLC acquired a new position in shares of Oscar Health during the 3rd quarter worth approximately $1,282,000. Finally, Assenagon Asset Management S.A. raised its stake in Oscar Health by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after purchasing an additional 507,009 shares during the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.